Crews Bank & Trust bought a new position in Colgate-Palmolive (NYSE:CL – Free Report) in the 4th quarter, HoldingsChannel.com reports. The firm bought 806 shares of the company’s stock, valued at approximately $73,000.
Several other institutional investors and hedge funds also recently made changes to their positions in CL. Union Bancaire Privee UBP SA purchased a new position in Colgate-Palmolive in the fourth quarter valued at about $32,000. Reston Wealth Management LLC bought a new stake in shares of Colgate-Palmolive in the third quarter valued at approximately $42,000. Capital Performance Advisors LLP purchased a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at approximately $53,000. Synergy Asset Management LLC bought a new position in Colgate-Palmolive in the 4th quarter worth approximately $49,000. Finally, Prospera Private Wealth LLC purchased a new position in Colgate-Palmolive in the 3rd quarter valued at approximately $64,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.
Analyst Ratings Changes
A number of equities analysts have recently commented on CL shares. Piper Sandler cut their price target on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a report on Monday, January 6th. TD Cowen cut their target price on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. JPMorgan Chase & Co. reduced their target price on Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating for the company in a report on Thursday, January 16th. Barclays cut their price objective on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research report on Friday, January 17th. Finally, Royal Bank of Canada reiterated a “sector perform” rating and issued a $101.00 target price on shares of Colgate-Palmolive in a research report on Wednesday. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and eleven have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $102.00.
Insider Buying and Selling
In other news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares of the company’s stock, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.34% of the stock is owned by company insiders.
Colgate-Palmolive Stock Performance
Colgate-Palmolive stock opened at $86.64 on Friday. The stock’s 50 day moving average is $91.52 and its 200 day moving average is $97.25. The company has a market capitalization of $70.78 billion, a P/E ratio of 24.82, a PEG ratio of 3.70 and a beta of 0.44. Colgate-Palmolive has a twelve month low of $82.68 and a twelve month high of $109.30. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46.
Colgate-Palmolive (NYSE:CL – Get Free Report) last issued its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 405.81% and a net margin of 14.27%. During the same quarter in the prior year, the firm earned $0.87 earnings per share. On average, equities research analysts predict that Colgate-Palmolive will post 3.58 earnings per share for the current fiscal year.
Colgate-Palmolive Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.31%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 57.31%.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also
- Five stocks we like better than Colgate-Palmolive
- Basic Materials Stocks Investing
- Nebius Group: Market Overreaction or Real AI Disruption?
- How to invest in marijuana stocks in 7 steps
- The Best Way to Invest in Gold Is…
- What is a Special Dividend?
- Why Nike Stock Could Be 2025’s Top Comeback Play
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.